BRCA1 and neoplasm: Following a consensus among European experts led by Vergote et al., it is recommended to conduct germline and/or tumor BRCA1/2 testing, as well as HRD tumor testing, at the primary diagnosis stage, preferably before the completion of first-line chemotherapy [43].